These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer]. Wang DF, Zhang GN, Peng CR, Shi Y, Shi XW. Zhonghua Fu Chan Ke Za Zhi; 2021 Jun 25; 56(6):385-392. PubMed ID: 34154313 [Abstract] [Full Text] [Related]
10. Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study. Gao Y, Li Y, Zhang C, Han J, Liang H, Zhang K, Guo H. J Ovarian Res; 2019 Sep 13; 12(1):85. PubMed ID: 31519183 [Abstract] [Full Text] [Related]
13. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study. Gueli Alletti S, Bottoni C, Fanfani F, Gallotta V, Chiantera V, Costantini B, Cosentino F, Ercoli A, Scambia G, Fagotti A. Am J Obstet Gynecol; 2016 Apr 13; 214(4):503.e1-503.e6. PubMed ID: 26529370 [Abstract] [Full Text] [Related]
14. A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer. Angeles MA, Rychlik A, Cabarrou B, Spagnolo E, Guyon F, Pérez-Benavente A, Gil-Moreno A, Siegrist J, Querleu D, Mery E, Gladieff L, Hernández A, Ferron G, Martinez A. Gynecol Oncol; 2020 Sep 13; 158(3):614-621. PubMed ID: 32709536 [Abstract] [Full Text] [Related]
17. Similar Overall Survival Using Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients Aged Over 75 Years with High-Grade Ovarian Cancer. Piedimonte S, Kessous R, Laskov I, Abitbol J, Kogan L, Yasmeen A, Salvador S, Lau S, Gotlieb WH. J Obstet Gynaecol Can; 2020 Nov 13; 42(11):1339-1345. PubMed ID: 32859533 [Abstract] [Full Text] [Related]
18. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer. Yao SE, Tripcony L, Sanday K, Robertson J, Perrin L, Chetty N, Land R, Garrett A, Obermair A, Nascimento M, Tang A, Jagasia N, Singh P, Nicklin J. Int J Gynecol Cancer; 2020 Dec 13; 30(12):1935-1942. PubMed ID: 33122245 [Abstract] [Full Text] [Related]
19. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy. Abitbol J, Gotlieb W, Zeng Z, Ramanakumar A, Kessous R, Kogan L, Pare-Miron V, Rombaldi M, Salvador S, Kucukyazici B, Brin S, How J, Lau S. Int J Gynecol Cancer; 2019 Nov 13; 29(9):1341-1347. PubMed ID: 31601648 [Abstract] [Full Text] [Related]
20. Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis. Ghirardi V, Moruzzi MC, Bizzarri N, Vargiu V, D'Indinosante M, Garganese G, Pasciuto T, Loverro M, Scambia G, Fagotti A. Gynecol Oncol; 2020 Apr 13; 157(1):209-213. PubMed ID: 31952843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]